Agios Pharmaceuticals, Inc. · Brief

Next report

4 days

Nov 5 · before openest.Q3 FY26

Earnings

Expected move

Inputs

±2.0%implied · report alone

29.9531.15

straddle ±8.5%

spot 30.55exp Nov 20ATM strike 30ATM straddle 3.05IV 53%

Oct 30 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

1 of 8≥ implied

avg implied: ±9.9%
avg realized: ±4.3%

Oct 31 '24±8.7%▼−4.04%×0.46

Feb 13 '25±10.8%▲+1.49%×0.14

May 1 '25±6.0%▲+4.21%×0.70

Jul 31 '25±12.0%▼−0.85%×0.07

Oct 30 '25±12.6%▲+2.91%×0.23

Feb 12 '26±9.8%▲+1.30%×0.13

Q1 FY26±9.2%▲+13.10%×1.42

Q2 FY26±9.7%▼−6.46%×0.66

quarterimplied−15%0+15%realized×

Q2 FY26±9.7%▼−6.46%×0.66

Q1 FY26±9.2%▲+13.10%×1.42

Feb '26±9.8%▲+1.30%×0.13

Oct '25±12.6%▲+2.91%×0.23

Jul '25±12.0%▼−0.85%×0.07

May '25±6.0%▲+4.21%×0.70

2 older reports

Feb '25±10.8%▲+1.49%×0.14

Oct '24±8.7%▼−4.04%×0.46

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

—

Linked exposure

AGIO report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 29impliedImplied move: ±15.1% into Nov 5 earnings (Oct 29 close).Source

Oct 15impliedImplied move: ±25.7% into Oct 29 earnings (Oct 15 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.